Related Experiment Videos
The pathology of hereditary breast cancer
1Department of Histopathology, Royal Free and University College Medical School, University College London, UK.
Disease Markers
|December 14, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assay.
Breast cancer research and treatment·2025
Hereditary breast cancer: syndromes, tumour pathology and molecular testing.
Histopathology·2022
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Role of health digital twins in oncology drug development - a primer.
Frontiers in oncology·2026
Research progress and clinical translation prospects of the urinary tract microbiome in prostate cancer.
Frontiers in immunology·2026
Therapeutic regulation of gut microbiota in gastric cancer: mechanisms, strategies, and clinical prospects.
Frontiers in microbiology·2026